| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
|
Grimison, P.S.
|
|
|
25 |
1 |
p. 143-148
|
artikel
|
| 2 |
Accelerated chemotherapy for germ cell cancer
|
Horwich, Alan
|
|
|
25 |
1 |
p. 7-8
|
artikel
|
| 3 |
A cohort study investigating aspirin use and survival in men with prostate cancer
|
Flahavan, E.M.
|
|
|
25 |
1 |
p. 154-159
|
artikel
|
| 4 |
A critical review of the analytical approaches for circulating tumor biomarker kinetics during treatment
|
Almufti, R.
|
|
|
25 |
1 |
p. 41-56
|
artikel
|
| 5 |
Adherence to consensus-based diagnosis and treatment guidelines in adult soft-tissue sarcoma patients: a French prospective population-based study †
|
Mathoulin-Pélissier, S.
|
|
|
25 |
1 |
p. 225-231
|
artikel
|
| 6 |
A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib
|
Ganjoo, K.N.
|
|
|
25 |
1 |
p. 236-240
|
artikel
|
| 7 |
Annals of Oncology: an editorial perspective
|
Soria, J.-C.
|
|
|
25 |
1 |
p. 5-6
|
artikel
|
| 8 |
Aprepitant does not alter prednisolone pharmacokinetics in patients treated with R-CHOP
|
Maie, K.
|
|
|
25 |
1 |
p. 298-299
|
artikel
|
| 9 |
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer
|
Hitt, R.
|
|
|
25 |
1 |
p. 216-225
|
artikel
|
| 10 |
A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive Italian women †
|
Cortesi, L.
|
|
|
25 |
1 |
p. 57-63
|
artikel
|
| 11 |
ATM down-regulation is associated with poor prognosis in sporadic breast carcinomas
|
Bueno, R.C.
|
|
|
25 |
1 |
p. 69-75
|
artikel
|
| 12 |
Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents
|
Merz, M.
|
|
|
25 |
1 |
p. 189-195
|
artikel
|
| 13 |
Clinicopathological features of nonsmall cell lung carcinomas with BRAF mutations
|
Kinno, T.
|
|
|
25 |
1 |
p. 138-142
|
artikel
|
| 14 |
Construction of novel immune-related signature for prediction of pathological complete response to neoadjuvant chemotherapy in human breast cancer
|
Sota, Y.
|
|
|
25 |
1 |
p. 100-106
|
artikel
|
| 15 |
Editorial board
|
|
|
|
25 |
1 |
p. ii-iii
|
artikel
|
| 16 |
Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
|
|
|
|
25 |
1 |
p. 300
|
artikel
|
| 17 |
Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer
|
Peeters, M.
|
|
|
25 |
1 |
p. 107-116
|
artikel
|
| 18 |
Final results from the prospective phase III WSG-ARA trial: impact of adjuvant darbepoetin alfa on event-free survival in early breast cancer †
|
Nitz, U.
|
|
|
25 |
1 |
p. 75-80
|
artikel
|
| 19 |
Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines †
|
Ransom, D.
|
|
|
25 |
1 |
p. 117-121
|
artikel
|
| 20 |
Final results of phase II trial of doxorubicin HCl liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma
|
Straus, D.J.
|
|
|
25 |
1 |
p. 206-210
|
artikel
|
| 21 |
How do the EMA and FDA decide which anticancer drugs make it to the market? A comparative qualitative study on decision makers’ views
|
Tafuri, G.
|
|
|
25 |
1 |
p. 265-269
|
artikel
|
| 22 |
Immunological off-target effects of standard treatments in gastrointestinal cancers
|
Duffy, A.G.
|
|
|
25 |
1 |
p. 24-32
|
artikel
|
| 23 |
Increased body mass index is associated with improved overall survival in diffuse large B-cell lymphoma
|
Weiss, L.
|
|
|
25 |
1 |
p. 171-176
|
artikel
|
| 24 |
instructions to authors
|
|
|
|
25 |
1 |
p. 301-307
|
artikel
|
| 25 |
Metastatic breast cancer: are we treating the same patients as in the past?
|
Ufen, M.-P.
|
|
|
25 |
1 |
p. 95-100
|
artikel
|
| 26 |
Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas
|
Egberts, F.
|
|
|
25 |
1 |
p. 246-250
|
artikel
|
| 27 |
Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials
|
Heng, D.Y.C.
|
|
|
25 |
1 |
p. 149-154
|
artikel
|
| 28 |
Parameningeal rhabdomyosarcoma in pediatric age: results of a pooled analysis from North American and European cooperative groups
|
Merks, J.H.M.
|
|
|
25 |
1 |
p. 231-236
|
artikel
|
| 29 |
PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies
|
Lee, J-m.
|
|
|
25 |
1 |
p. 32-40
|
artikel
|
| 30 |
Patterns and trends in esophageal cancer mortality and incidence in Europe (1980–2011) and predictions to 2015
|
Castro, C.
|
|
|
25 |
1 |
p. 283-290
|
artikel
|
| 31 |
Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer
|
Blaszkowsky, L.S.
|
|
|
25 |
1 |
p. 121-126
|
artikel
|
| 32 |
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
|
Alberti, P.
|
|
|
25 |
1 |
p. 257-264
|
artikel
|
| 33 |
Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses
|
Ioannidis, J.P.A.
|
|
|
25 |
1 |
p. 16-23
|
artikel
|
| 34 |
Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary
|
Uzan, C.
|
|
|
25 |
1 |
p. 166-171
|
artikel
|
| 35 |
Quality-of-life outcomes from a randomized phase III trial of dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin as a first-line treatment for stage II–IV ovarian cancer: Japanese Gynecologic Oncology Group Trial (JGOG3016)
|
Harano, K.
|
|
|
25 |
1 |
p. 251-257
|
artikel
|
| 36 |
Radiation therapy for extramammary Paget's disease: treatment outcomes and prognostic factors
|
Hata, M.
|
|
|
25 |
1 |
p. 291-297
|
artikel
|
| 37 |
Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancer
|
Twelves, C.
|
|
|
25 |
1 |
p. 132-138
|
artikel
|
| 38 |
Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network
|
Beau-Faller, M.
|
|
|
25 |
1 |
p. 126-131
|
artikel
|
| 39 |
Selection of oncology medicines in low- and middle-income countries
|
Bazargani, Y.T.
|
|
|
25 |
1 |
p. 270-276
|
artikel
|
| 40 |
Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents
|
Dimopoulos, M.A.
|
|
|
25 |
1 |
p. 195-200
|
artikel
|
| 41 |
Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the Netherlands
|
Janssen-Heijnen, M.L.G.
|
|
|
25 |
1 |
p. 64-68
|
artikel
|
| 42 |
Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40—GeparQuattro)
|
von Minckwitz, G.
|
|
|
25 |
1 |
p. 81-89
|
artikel
|
| 43 |
Table of Contents
|
|
|
|
25 |
1 |
p. iv-vii
|
artikel
|
| 44 |
thanks to referees 2013
|
|
|
|
25 |
1 |
p. 1-4
|
artikel
|
| 45 |
The clinical features, management and prognostic effects of pathological fractures in a multicenter series of 373 patients with diffuse large B-cell lymphoma of the bone
|
Govi, S.
|
|
|
25 |
1 |
p. 176-181
|
artikel
|
| 46 |
The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO)
|
Popescu, R.A.
|
|
|
25 |
1 |
p. 9-15
|
artikel
|
| 47 |
The impact of activated p-AKT expression on clinical outcomes in diffuse large B-cell lymphoma: a clinicopathological study of 262 cases
|
Hong, J.Y.
|
|
|
25 |
1 |
p. 182-188
|
artikel
|
| 48 |
The impact of allogeneic stem cell transplantation on the natural course of poor-risk chronic lymphocytic leukemia as defined by the EBMT consensus criteria: a retrospective donor versus no donor comparison †
|
Herth, I.
|
|
|
25 |
1 |
p. 200-206
|
artikel
|
| 49 |
The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis
|
Rossi, C.R.
|
|
|
25 |
1 |
p. 240-246
|
artikel
|
| 50 |
The prognostic significance of left ventricular ejection fraction in patients with advanced cancer treated in phase I clinical trials
|
Said, R.
|
|
|
25 |
1 |
p. 276-282
|
artikel
|
| 51 |
The rs1800716 variant in CYP2D6 is associated with an increased double endometrial thickness in postmenopausal women on tamoxifen
|
Dieudonné, A.-S.
|
|
|
25 |
1 |
p. 90-95
|
artikel
|
| 52 |
Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma
|
Meyer, A.H.
|
|
|
25 |
1 |
p. 210-215
|
artikel
|
| 53 |
Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study
|
Fotopoulou, C.
|
|
|
25 |
1 |
p. 160-165
|
artikel
|
Tijdschrift beschrijving